Frontier Biotechnologies Inc. (SHA:688221)
China
· Delayed Price · Currency is CNY 8.52
-0.12 (-1.39%)
At close: Apr 25, 2025, 2:57 PM CST
Frontier Biotechnologies Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | - | -328.96 | -356.76 | -260.06 | -230.73 | Upgrade
|
| Depreciation & Amortization | - | 26.06 | 51.28 | 44.04 | 38.19 | Upgrade
|
| Other Amortization | - | 20.67 | 1.3 | 1.18 | 1.26 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 3.08 | 0 | -0 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 3.22 | 0.01 | - | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -16.66 | -19.94 | -38.01 | -5.7 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.41 | 1.6 | 1.22 | 0.4 | Upgrade
|
| Other Operating Activities | - | 9.2 | 7.27 | -7.19 | 0.93 | Upgrade
|
| Change in Accounts Receivable | - | 2.43 | -58.03 | 5.73 | -27.68 | Upgrade
|
| Change in Inventory | - | -3.39 | -17.37 | -21.97 | 1.48 | Upgrade
|
| Change in Accounts Payable | - | 16.56 | 99.38 | 24.83 | 31.61 | Upgrade
|
| Change in Other Net Operating Assets | - | 0.22 | 2.24 | 7.16 | 20.05 | Upgrade
|
| Operating Cash Flow | - | -267.17 | -289.04 | -243.07 | -170.17 | Upgrade
|
| Capital Expenditures | - | -129.35 | -140.37 | -327.15 | -186.41 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.24 | 0 | 0.16 | - | Upgrade
|
| Investment in Securities | - | 284 | -1 | 271 | -784 | Upgrade
|
| Other Investing Activities | - | 17.81 | 24.11 | 37.73 | 5.13 | Upgrade
|
| Investing Cash Flow | - | 172.7 | -117.27 | -18.26 | -965.28 | Upgrade
|
| Long-Term Debt Issued | - | 312.8 | 202.57 | 279.69 | 14.99 | Upgrade
|
| Long-Term Debt Repaid | - | -216.64 | -220.84 | -32 | -19.13 | Upgrade
|
| Net Debt Issued (Repaid) | - | 96.16 | -18.27 | 247.68 | -4.14 | Upgrade
|
| Issuance of Common Stock | - | - | 195.67 | - | 1,751 | Upgrade
|
| Common Dividends Paid | - | -14.46 | -15.13 | -5.54 | -1.36 | Upgrade
|
| Other Financing Activities | - | -11.41 | -2.8 | -22.82 | 2.2 | Upgrade
|
| Financing Cash Flow | - | 70.29 | 159.46 | 219.32 | 1,748 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.05 | 0.16 | 0.23 | -0.48 | Upgrade
|
| Net Cash Flow | - | -24.23 | -246.68 | -41.78 | 611.7 | Upgrade
|
| Free Cash Flow | - | -396.52 | -429.42 | -570.22 | -356.59 | Upgrade
|
| Free Cash Flow Margin | - | -347.07% | -506.74% | -1407.84% | -764.83% | Upgrade
|
| Free Cash Flow Per Share | - | -1.06 | -1.18 | -1.58 | -1.24 | Upgrade
|
| Cash Income Tax Paid | - | -6.39 | -54.05 | -12.26 | 1.13 | Upgrade
|
| Levered Free Cash Flow | - | -343.6 | -403.69 | -482.68 | -273.77 | Upgrade
|
| Unlevered Free Cash Flow | - | -338.31 | -400.72 | -481.72 | -272.92 | Upgrade
|
| Change in Net Working Capital | - | 40.77 | 66.04 | 6.08 | -7.68 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.